CGTX logo

Cognition Therapeutics (CGTX) Free Cash Flow

CGTX Annual FCF

-$16.16 M
+$2.54 M+13.57%

31 December 2023

CGTX Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CGTX Quarterly FCF

-$6.85 M
-$851.00 K-14.18%

30 September 2024

CGTX Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CGTX TTM FCF

-$25.58 M
-$2.63 M-11.47%

30 September 2024

CGTX TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CGTX Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.6%-62.4%-22.6%
3 y3 years-369.5%-62.4%-22.6%
5 y5 years-398.6%-62.4%-22.6%

CGTX Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-341.9%+13.6%-6883.2%+32.8%-604.5%at low
5 y5-year-398.6%+13.6%-1417.5%+32.8%-5019.4%at low
alltimeall time-398.6%+13.6%-1417.5%+32.8%-5019.4%at low

Cognition Therapeutics Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$6.85 M(+14.2%)
-$25.58 M(+11.5%)
June 2024
-
-$6.00 M(-17.2%)
-$22.95 M(+11.1%)
Mar 2024
-
-$7.24 M(+32.0%)
-$20.66 M(+27.8%)
Dec 2023
-$16.16 M(-13.6%)
-$5.49 M(+30.0%)
-$16.16 M(-22.6%)
Sept 2023
-
-$4.22 M(+13.6%)
-$20.87 M(+25.1%)
June 2023
-
-$3.71 M(+35.3%)
-$16.68 M(-9.0%)
Mar 2023
-
-$2.75 M(-73.1%)
-$18.33 M(-2.0%)
Dec 2022
-$18.70 M
-$10.19 M(>+9900.0%)
-$18.70 M(+122.4%)
Sept 2022
-
-$27.00 K(-99.5%)
-$8.41 M(-19.4%)
June 2022
-
-$5.36 M(+71.7%)
-$10.43 M(+74.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$3.12 M(-3191.1%)
-$5.98 M(+64.7%)
Dec 2021
-$3.66 M(+6.2%)
$101.00 K(-104.9%)
-$3.63 M(-13.8%)
Sept 2021
-
-$2.05 M(+125.3%)
-$4.21 M(+34.9%)
June 2021
-
-$910.00 K(+17.9%)
-$3.12 M(-34.0%)
Mar 2021
-
-$772.00 K(+60.8%)
-$4.74 M(+37.5%)
Dec 2020
-$3.44 M(+6.2%)
-$480.00 K(-50.1%)
-$3.44 M(+16.2%)
Sept 2020
-
-$961.00 K(-61.9%)
-$2.96 M(+48.0%)
June 2020
-
-$2.52 M(-585.0%)
-$2.00 M(-485.0%)
Mar 2020
-
$520.00 K
$520.00 K
Dec 2019
-$3.24 M
-
-

FAQ

  • What is Cognition Therapeutics annual free cash flow?
  • What is the all time high annual FCF for Cognition Therapeutics?
  • What is Cognition Therapeutics annual FCF year-on-year change?
  • What is Cognition Therapeutics quarterly free cash flow?
  • What is the all time high quarterly FCF for Cognition Therapeutics?
  • What is Cognition Therapeutics quarterly FCF year-on-year change?
  • What is Cognition Therapeutics TTM free cash flow?
  • What is the all time high TTM FCF for Cognition Therapeutics?
  • What is Cognition Therapeutics TTM FCF year-on-year change?

What is Cognition Therapeutics annual free cash flow?

The current annual FCF of CGTX is -$16.16 M

What is the all time high annual FCF for Cognition Therapeutics?

Cognition Therapeutics all-time high annual free cash flow is -$3.24 M

What is Cognition Therapeutics annual FCF year-on-year change?

Over the past year, CGTX annual free cash flow has changed by +$2.54 M (+13.57%)

What is Cognition Therapeutics quarterly free cash flow?

The current quarterly FCF of CGTX is -$6.85 M

What is the all time high quarterly FCF for Cognition Therapeutics?

Cognition Therapeutics all-time high quarterly free cash flow is $520.00 K

What is Cognition Therapeutics quarterly FCF year-on-year change?

Over the past year, CGTX quarterly free cash flow has changed by -$2.63 M (-62.38%)

What is Cognition Therapeutics TTM free cash flow?

The current TTM FCF of CGTX is -$25.58 M

What is the all time high TTM FCF for Cognition Therapeutics?

Cognition Therapeutics all-time high TTM free cash flow is $520.00 K

What is Cognition Therapeutics TTM FCF year-on-year change?

Over the past year, CGTX TTM free cash flow has changed by -$4.71 M (-22.56%)